Chugai Pharmaceutical Co. Ltd. has unveiled a new $1bn+ investment in a major new core global R&D facility in Yokohama near Tokyo, as it looks to adopt and integrate new technologies and speed up the development process.
Construction of the Chugai Life Science Park Yokohama will start this August on an already owned site in the city, with the completion of buildings scheduled for